GAIA
Healthcare Software · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hans-henny-jahnn-weg 53, Hamburg, Hambur...Phone Number
+49 403510520Website
www.gaia-group.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About GAIA
GAIA is a global leader in digital therapeutics (DTx), launching its first product successfully in 2001. With its stringent focus on research and development of evidence based, fully-automated online interventions the company continuously shifts benchmarks when it comes to effect sizes and safety profiles for digital therapeutics in neuroscience, immunology, oncology, or behavioral health. With more than 150 experts in the field of Medicine, Psychology, Behavioral Medicine, Software Engineering as well as Regulatory and Market Access, GAIA is one of the most experienced and largest global players in the development of next generation digital solutions to support and treat patients with a broad variety of medical conditions.Explore more
GAIA Org Chart
BB
Nursing Technician
TD
Assistente Administrativa
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GAIA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
GAIA, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once GAIA has new funding data
Product Launch: Get notified when GAIA launches new products
Earning: See what the market has to say on GAIA recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if GAIA is spiking on competitors!
Check if GAIA has recently received funding, and reach out quickly before it becomes old news!
Click to see if GAIA had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GAIA
Recommended Actions
Reach out to Masked Content who joined GAIA as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
GAIA is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
GAIA is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about GAIA.
GAIA Tech Stack
A closer look at the technologies used by GAIA
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
GAIA News & Media
Orexo Acquires Exclusive US Rights to Commercialize deprexis®, A World-leading Digital Therapy to Help Patients Manage the Symptoms of Depression
Orexo AB (publ.) today announces it has acquired the exclusive US rights to GAIA AG's (GAIA) deprexis®, a digital therapy to help patients manage their symptoms of depression and one of the most researched digital therapies in the world. Today's announcement follows two earlier agreements with GAIA where Orexo acquired the exclusive US commercial rights to vorvida® which has been scientifically proven to reduce risky drinking patterns in adults with alcohol use disorder (AUD), andOrexo Submits Application for vorvida® to the FDA to Enable Commercialization in the US
UPPSALA, Sweden, March 6, 2020 /PRNewswire/ -- Orexo AB (publ), today announces it has submitted an application to the US Food and Drug Administration (FDA) for vorvida® to enable commercialization in the US. vorvida®, is a digital therapy with clinically proven efficacy for the treatment...Orexo Acquires Exclusive US Rights to Commercialize Vorvida®, a Digital Therapy for Alcohol Use Disorder with Scientifically Proven Efficacy
Orexo AB (publ), the fully integrated specialty pharmaceutical company with the aim of becoming a leader within treatment of addiction, today announces it has acquired the exclusive US rights to vorvida®, a digital therapy for the treatment of Alcohol Use Disorder (AUD), from GAIA AG (GAIA), a global leader in digital therapeutics. Today's news follows an earlier agreement with GAIA in August 2019, for the exclusive global commercial rights to OXD01, a new digital therapyOrexo Acquires Exclusive US Rights to Commercialize Vorvida®, a Digital Therapy for Alcohol Use Disorder with Scientifically Proven Efficacy
UPPSALA, Sweden, Nov. 27, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company with the aim of becoming a leader within treatment of addiction, today announces it has acquired the exclusive US rights to vorvida®, a digital therapy for the treatment...
Read more news
Top Healthcare Software Companies
See more top companies
Frequently Asked Questions Regarding GAIA
Sign Up For FreeTo access detailed company insights
GAIA is a global leader in digital therapeutics (DTx), launching its first product successfully in 2001. With its stringent focus on research and development of evidence based, fully-automated online interventions the company continuously shifts benchmarks when it comes to effect sizes and safety profiles for digital therapeutics in neuroscience, i... Read More
